جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

17 مُخرَج نتائج البحث عن «Immunotherapy»

مراجعةوصول مفتوح20269استشهاد· Semantic Scholar

Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies

Frontiers in Immunology · مجلد 16 · 1690464-1690464

Gliomas, and particularly glioblastoma (GBM), remain among the most lethal primary brain tumors, with outcomes constrained by extensive intra tumor heterogeneity, a profoundly immunosuppressive tumor microenvironment (TME), and the restrictive nature of the blood-brain barrier (BBB). Although immunotherapies, including immune checkpoint inhibitors, chimeric antigen receptor (CAR) T and NK cells, and oncolytic virotherapy, have redefined treatment paradigms in other malignancies, their efficacy in gliomas has been modest, limited by low tumor mutational burden, antigenic plasticity, metabolic suppression, and therapy-associated immunosuppression. Recent advances in multi-antigen targeting, metabolic reprogramming, and innovative delivery strategies have enhanced preclinical efficacy, while the integration of emerging biomarkers such as ADAMTSL4, ACSS3, and radiomics-derived immune signatures offers opportunities for precision patient stratification. Converging developments in real-time molecular monitoring, spatial immunoprofiling, and rationally designed combination regimens hold the potential to recalibrate the glioma immune landscape, paving the way toward clinically impactful and durable immunotherapeutic responses.

glioma immunotherapyglioblastomaimmunosuppressive tumor microenvironmentblood-brain barrier
مقالمفتوح (مستودع)20253استشهاد· Semantic Scholar

Deciphering immune evasion mechanisms in precision oncology: insights from single-cell multiomics approaches

International Journal of Surgery · مجلد 112 (2) · 4563-4574

BACKGROUND: Cancer poses a persistent global health challenge, and one of its most formidable characteristics is the ability to evade immune detection. Understanding these immune evasion mechanisms is essential for improving therapeutic outcomes, especially in the era of personalized medicine. Recent advances in single-cell multiomics technologies have opened new avenues for exploring tumor-immune interactions at unprecedented resolution. OBJECTIVE: This review aims to critically examine how single-cell multiomics platforms, integrating genomics, transcriptomics, epigenomics, and proteomics, have been applied to identify immune evasion mechanisms in cancer and how these findings contribute to the development of precision oncology. METHODS: A structured literature search was conducted in PubMed, Scopus, and Web of Science, focusing on studies published between 2018 and 2025. Relevant research articles employing single-cell multiomics in the context of cancer immune evasion were selected, analyzed, and thematically organized according to the type of omics technology used and clinical relevance. RESULTS: The findings highlight that single-cell multiomics enables the detection of rare immune-resistant cellular subtypes, the identification of altered immunoregulatory pathways, and the characterization of epigenetic reprogramming events involved in immune escape. This integrative approach reveals dynamic and context-dependent mechanisms by which tumors adapt and resist immunotherapy. CONCLUSIONS: Single-cell multiomics technologies provide a comprehensive and nuanced understanding of cancer immune evasion. These insights not only explain failures in current immunotherapy strategies but also inform the development of more effective and personalized treatment interventions. The integration of these platforms into clinical research represents a significant step toward overcoming immune resistance in oncology.

tumor immune evasiontumor immune microenvironmentsingle-cell multi-omicsprecision oncology
مراجعةوصول مفتوح202412استشهاد· Semantic Scholar

Subclinical mastitis of buffaloes in Asia: prevalence, pathogenesis, risk factors, antimicrobial resistance, and current treatment strategies

Journal of Animal Science and Technology · مجلد 68 (1) · 18-49

Subclinical mastitis (SCM) remains a significant challenge in buffalo farming across Asia, impacting both animal welfare and economic productivity. In this review, we assessed the status, pathogenesis, risk factors, antimicrobial resistance (AMR) and therapeutic measures associated with SCM in buffalo populations. This study revealed a pooled prevalence of SCM in Asia at 41.51% (2,513/6,054; 95% CI: 40.26–42.76) with considerable variation observed across different regions. Notably, Turkey exhibited the highest pooled prevalence at 61.1% (95% CI: 43.46–76.86), while Nepal reported the lowest pooled prevalence at 23.7% (95% CI: 19.15–28.82). Staphylococcus spp. emerged as the most common mastitogen with the California Mastitis Test (CMT) identified as the primary diagnostic method. Risk factors for SCM exhibited variability among studies, reflecting the diverse husbandry practices and environmental conditions across Asian buffalo farming regions. Furthermore, AMR poses a significant concern, with beta-lactam antibiotics (penicillin, ampicillin, oxacillin) commonly found to be resistant in many studies. Herbal therapy derived from both animal and plant sources, along with immunotherapy, emerged as effective strategies for controlling and preventing SCM and clinical mastitis in buffalo. Importantly, these approaches offer promising solutions for combating AMR while promoting sustainable mastitis management practices in Asian buffalo farming. The review emphasizes the need to understand the prevalence, causes, and management of SCM in buffaloes across Asia, calling for targeted interventions and further research to tackle this widespread issue.

subclinical mastitisbuffaloprevalencepathogenesis
مراجعةوصول مغلق202220استشهاد· Semantic Scholar

Immunology of Osteoporosis: Relevance of Inflammatory Targets for the Development of Novel Interventions

Immunotherapy · مجلد 14 (10) · 815-831

Osteoporosis is recognized as low bone mass and deteriorated bone microarchitecture. It is the leading cause of fractures and consequent morbidity globally. The established pathophysiological evidence favors the endocrine factors for osteoporosis and the role of the immune system on the skeletal system has been recently identified. Due to the common developmental niche bone and immune system interactions have led to the emergence of osteoimmunology. Immune dysregulation can initiate inflammatory conditions that adversely affect bone integrity. The role of immune cells, such as T-lymphocytes subsets (Th17), cannot be neglected in the pathogenesis of osteoporosis. Local inflammation within the bone from any cause attracts immune cells that participate in the activation of osteoclasts. This work summarizes the present knowledge of osteoimmunology in reference to osteoporosis and identifies novel targets for immunotherapy of osteoporosis.

osteoporosisosteoimmunologybone-immune interactionTh17 cells
مراجعةوصول مفتوح202145استشهاد· Semantic Scholar

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

Pharmaceuticals · مجلد 14 (10) · 970-970

The advancement in therapy has provided a dramatic improvement in the rate of recovery among cancer patients. However, this improved survival is also associated with enhanced risks for cardiovascular manifestations, including hypertension, arrhythmias, and heart failure. The cardiotoxicity induced by chemotherapy is a life-threatening consequence that restricts the use of several chemotherapy drugs in clinical practice. This article addresses the prevalence of cardiotoxicity mediated by commonly used chemotherapeutic and immunotherapeutic agents. The role of susceptible genes and radiation therapy in the occurrence of cardiotoxicity is also reviewed. This review also emphasizes the protective role of antioxidants and future perspectives in anticancer drug-induced cardiotoxicities.

chemotherapy-induced cardiotoxicitypharmacogeneticsimmunotherapy cardiotoxicityhypertension
مقالمفتوح (مستودع)20218استشهاد· Semantic Scholar

Formulation and in-vitro characterization of fast-disintegrating herbal extract sublingual immunotherapy tablet for peanut-induced allergic asthma

Saudi Journal of Biological Sciences · مجلد 29 (3) · 1283-1297

Background: Allergen immunotherapy (AIT) involves the regimen of gradually incrementing doses of the allergen, thereby inducing desensitization and tolerance. Sublingual Immunotherapy tablets (SLIT-tablets) have been formulated for several allergies and had manifested efficacy for allergic rhinitis and allergic asthma. SLIT promises an alternative method to other routes of AIT enabling patients to self-administer AIT. Objective: The study aimed to formulate fast disintegrating SLIT containing crude peanut extract for peanut-induced allergic asthma. Methods: The crude peanut extract was prepared by a simple extraction method and was subjected to quantitative and qualitative analysis. The extract was also characterised for its physical properties. The preformulation study for the extract and excipients of the tablet was performed using FT-IR spectroscopy and Differential scanning calorimetry. The tablet powder blends were characterised for pre-compression properties. The SLIT tablets were developed by direct compression and the post-compression evaluation was performed. Results: The results of the quantitative and qualitative analysis of extract confirmed the presence of peanut proteins in the extract. The preformulation studies using FT-IR spectroscopy and Differential Scanning Calorimetry revealed that there is no significant interaction between the CPE and excipients. The pre-compression characterisation showed that the powder blends had good flowproperties. Three doses of SLIT tablets were formulated with each dose containing four batches and the tablet of each dose was optimized by studying the effect of varying concentrations of super disintegrants on disintegration time and dissolution rate. The post compression characterization of the tablets was performed and the optimized batch of the three doses with the concentration of 5% crospovidone and 2% croscarmellose sodium showed less wetting time and high-water absorption ratio, shorter disintegration time of 14secs and maximum drug release of >90% within 2-3 min. Conclusion: The results indicated the suitability of formulated SLIT tablets for peanut induced allergic asthma.

sublingual immunotherapypeanut allergyallergic asthmafast disintegrating tablets